RxDoctor Payments Data

Carrie Perry

Adult Health · Baton Rouge, LANPI 1396285821

Payments from drug & device makers

What this record shows

28 manufacturers reported payments, led by Novartis at 47.2% of the total.

$6,187in general payments, 2019–2025

Across 199 payments — averaging $31.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3K
  • AstraZeneca$573
  • Stemline Therapeutics Inc.$407
  • Merck$358
  • Daiichi Sankyo Inc.$328
  • Eisai Inc.$305
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$3,58958%
  • Other$2,59842%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,187 in reported general payments places this provider in the 85th percentile of 203 adult health providers in Louisiana.

See all adult health providers in Louisiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron Hcl92$485
Lidocaine-PrilocaineLidocaine/Prilocaine29$374
Anastrozole18$278
Dexamethasone18$216
Promethazine Hcl20$85
Levofloxacin11$24

Paid to pharmacies, not to this prescriber.

Other adult health in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →